U.S. FDA approves TB Alliance's treatment for drug|resistant ...

TB Alliance's Pretomanid receives FDA approval for Tuberculosis

On August 14, TB Alliance's pretomanid was approved by the FDA for the treatment of a specific type of highly treatment-resistant tuberculosis (TB) of the ...

FDA approves effective new treatment for extremely drug-resistant ...

The TB Alliance, a New York-based nonprofit, was responsible for bringing out pretomanid. This brought another relevant issue to light: new ...

New Treatment for Highly Drug-Resistant Tuberculosis (TB) was ...

Pretomanid is expected to be available in the United States by the end of this year. In addition to the U.S. FDA, TB Alliance has submitted ...

New drug to treat deadliest TB approved by US drug regulator | Health

Pretamonid, a novel compound developed by the non-profit organization TB Alliance, was approved by the US Food & Drug Administration (FDA) ...

FDA approves TB pill that cures more hard-to treat patients - WSPA

U.S. regulators have approved a new tuberculosis medicine that shortens and improves treatment ... The Food and Drug Administration approved ...

FDA approves TB pill that cures more hard-to treat patients

U.S. regulators have approved a new tuberculosis medicine that ... TB Alliance in August 2019 shows the drug pretomanid. (Roksana ...

Novel 6-Month Treatment for Drug-Resistant Tuberculosis, United ...

The US Food and Drug Administration approved a 6-month regimen of pretomanid, bedaquiline, and linezolid for extensively drug-resistant or ...

FDA approves TB pill that cures more hard-to-treat patients - KSN-TV

It's the first TB drug from a nonprofit group, the TB Alliance. Formed to come up with better treatments, the group developed pretomanid with ...

New treatment approved for drug-resistant tuberculosis | fox43.com

Pretomanid, a compound developed by the nonprofit TB Alliance and approved by the FDA on Wednesday, forms part of a three-drug regimen that ...

Global Alliance for TB Drug Development

In August 2019, TB Alliance received its first regulatory approval from the United States Food and Drug Administration (U.S. FDA) for pretomanid in a ...

FDA Approves New Treatment For Highly Drug-Resistant Forms Of ...

Pretomanid is expected to be available in the United States by the end of this year. In addition to the U.S. FDA, TB Alliance has submitted.

TB Alliance: New TB Drug Approved to Treat the Deadliest Forms of ...

Pretomanid is the second drug approved for drug-resistant TB by the U.S. FDA in more than 40 years, and the first approved as part of a full ...

Pretomanid: The latest USFDA-approved anti-tuberculosis drug

Pretomanid has been approved for treatment of adults with pulmonary XDR-TB or treatment-intolerant or non-responsive MDR-TB.

FDA approves drug for most deadly form of tuberculosis

... treatment regimen for the most deadly strain of tuberculosis, the U.S. Food and Drug Administration announced Wednesday.

Treatment for drug-resistant TB - MedAccess

Pretomanid was approved by the US Food and Drug Administration in 2019 and is registered in more than 20 countries and the European Union. When the WHO ...

New antibiotic approved for drug-resistant tuberculosis

The antibiotic, called pretomanid, was developed by a nonprofit group called TB Alliance at a time when few companies are investing in the ...

FDA approves TB pill that cures more hard-to-treat patients | AP News

U.S. regulators have approved a new tuberculosis medicine that shortens ... It's the first TB drug from a nonprofit group, the TB Alliance.

FDA OKs 'Game Changer' Pretomanid for Highly Resistant TB

The US Food and Drug Administration (FDA) approved pretomanid today, a "major" breakthrough treatment for the most drug-resistant tuberculosis (TB)

FDA Approves New Treatment for Highly Drug-Resistant Forms of ...

organization TB Alliance, was approved by the U.S. Food & Drug Administration (FDA) today for treating some of the most drug-resistant forms ...

US FDA Approves New TB Drug in Treatment to Cure Practically ...

... Global Health Technologies Coalition, on the US Food and Drug Administration's approval of pretomanid, a new drug developed by the nonprofit TB Alliance.